(NASDAQ: XOMA) Xoma Royalty's forecast annual revenue growth rate of 41.73% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 118.38%, and while it is forecast to beat the US market's average forecast revenue growth rate of 23.25%.
Xoma Royalty's revenue in 2026 is $47,106,000.On average, 7 Wall Street analysts forecast XOMA's revenue for 2026 to be $808,629,009, with the lowest XOMA revenue forecast at $627,043,187, and the highest XOMA revenue forecast at $1,196,665,925. On average, 4 Wall Street analysts forecast XOMA's revenue for 2027 to be $870,135,882, with the lowest XOMA revenue forecast at $795,837,264, and the highest XOMA revenue forecast at $938,763,038.
In 2028, XOMA is forecast to generate $1,788,367,735 in revenue, with the lowest revenue forecast at $929,574,776 and the highest revenue forecast at $3,075,838,954.